Pilot Study of B-Type Natrieutic Peptide (BNP) Levels in Patients With Congenital Heart Disease(BNP)
NCT ID: NCT00308230
Last Updated: 2014-07-17
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2001-12-31
2004-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Provider Notification for High B-type Natriuretic Peptide Values
NCT01734135
A Study Evaluating Biomarkers in Participants With Heart Failure (MK-0000-344)
NCT02364752
Exploration of Dyspnea at Non-high Brain Natriuretic Peptide (BNP)
NCT03550235
A Health Economic Evaluation of Using N-Terminal Pro Brain Natriuretic Peptide (NT-Pro BNP) in Acute Heart Failure
NCT03669198
Pulmonary Arteyr Denervation for HF Without PH
NCT06323512
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
BNP Levels: Approximately 7 cc of blood will be collected. The blood will be analyzed for B-type natriuretic peptide on a rapid assay in the clinic.
Exercise Tolerance: will be measured by a 6 minute walk test on day of visit Echocardiogram: A complete echocardiogram including assessment of anatomy, ventricular function and valvular function will be performed following the phlebotomy.
Quality of life: The minnesota living with heart failure questionnaire will be administered on the day of collection of neurohormonal levels. A research nurse will be available to assist the patient if needed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal Heart
Control Group with Normal Heart
Six minute walk test
Minnesota Living with Heart Failure Questionnaire
Congenital Heart Disease
Tetralogy of Fallot, DTGA, CCTGA
Six minute walk test
Minnesota Living with Heart Failure Questionnaire
Heart Failure
Left ventricular heart failure, no congestive heart disease
Six minute walk test
Minnesota Living with Heart Failure Questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Six minute walk test
Minnesota Living with Heart Failure Questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
18 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Emory University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wendy M. Book
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wendy M Book, M.D.
Role: PRINCIPAL_INVESTIGATOR
Emory University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00045884
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.